Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Percepta for Cognitive Optimization: A 6-Month Randomized Controlled Trial With Neurocognitive, Wearable, and Participant-Reported Outcomes in Adults With Mild Cognitive Impairment

NCT07612449 is registered in ClinicalTrials.gov with Cerebrum DAO Association as lead sponsor.

NCT NCT07612449
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07612449 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Percepta for Cognitive Optimization: A 6-Month Randomized Controlled Trial With Neurocognitive, Wearable, and Participant-Reported Outcomes in Adults With Mild Cognitive Impairment
Lead sponsor
Cerebrum DAO Association
Phase
Not applicable
Overall status
Recruiting
Start date
September 14, 2026
Completion date
June 1, 2027
Enrollment
154 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

memory, mild cognitive impairment (mci)